Thanks to the rapid development of sequencing technology, an increasing number of studies investigated the APP, PSEN1, and PSEN2 genetic spectrum worldwide, demonstrating their significant role in AD pathogenesis (Sassi et al., 2014; Gao et al., 2019). The gene discussed is APP; the disease is Alzheimer disease.